Dermatology

The wound care matrix is composed of hydrolyzed fish collagen infused with cod liver oil and other plant-derived oil and wax to aid in the natural wound healing process.

Investigators hope that the emerging method of managing these atopic diseases can help remove racial and socioeconomic barriers to care.

Investigators believe their study shows the efficacy and safety of the 2 biologic agents, which are known to have anti-inflammatory and immunosuppressant qualities.

Investigators believe the treatment strategy can go on to treat other “difficult-to-treat” areas of the body such as palms, elbows, and lips.

A new study shows that research and educational resources are greatly lacking regarding skin color and dermatology education.

Investigators found that patients who were not treated with biologic medications were at a significantly increased risk of developing psoriatic arthritis.

Though investigators called for more research on the biologic, recent data showed patients treated with bimekizumab recorded improved skin pain when compared to placebo and adalimumab.

Investigators write that methods such as dermatoscopy can result in early recognition of unstable patches and lead to appropriate medical treatment for patients with vitiligo.

A new study showed about half of all vitiligo patients from a care system were burdened with the sleeping disorder.

According to a claims analysis, sunburn was also commonly diagnosed in female and young patients.

The prevalence of striae distensae was notably higher in psoriasis than atopic dermatitis.

Brett King, MD, PhD, encourages dermatologists to wait for more clinical data before making any assumptions on the drug class' safety and selectivity.

Brett King, MD, PhD, compares the efficacy of JAKs with biologics in the atopic dermatitis setting.

Experts in dermatology discuss the clinical presentation of atopic dermatitis, common comorbidities associated with the disease, and its impact on patient quality of life.

Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, and Douglas DiRuggiero, DMSc, PA-C, provide an overview of atopic dermatitis including prevalence, age of onset, and diagnosis.

Brett King, MD, PhD, provides an overview of JAK inhibitors and their interaction with the JAK-STAT pathway.

Studies are needed to determine the best treatment regimen for these patients.

Researchers record more depressive symptoms in patients with psoriatic arthritis, which they believe incentivizes doctors to utilize screening methods that focus on the mental health of a patient.

Treatment was associated with reductions in IGA scores as well as inflammatory and non-inflammatory lesion counts.

The selective topical PDE4 inhibitor demonstrated rapid improvements in IGA and EASI scores and high tolerability in pediatric populations.

The newest FDA indication allows for greater distribution to younger but equally vulnerable immunocompromised patients.

On the latest Derm Discussions, Brett King, MD, PhD, joins Brad Glick, DO, to discuss the potential of the JAK inhibitor class for dermatology.

Males and patients with higher disease severity were more likely to attend program sessions.

More research is needed to understand the pathogenesis underlying this association.

The FDA will also not meet the PDUFA date for tofacitinib for the treatment of active ankylosing spondylitis.

Gastrointestinal infections were the most common serious infections associated with biologics, according to a cohort analysis.

Patients with psoriatic arthritis often feel limited in their knowledge on medications and treatments, which investigators said leads to a lack of treatment and increased risk of disability.

Upadacitinib has shown promising results for a variety of diseases such as severe atopic dermatitis and psoriatic arthritis, but its future remains uncertain.

Less than half of affected patients (42.86%) indicated previous history of conjunctivitis prior to initiating dupilumab treatment.

Research on the effect of methotrexate and other immunosuppressants in regard to the COVID-19 vaccine are encouraging yet unfinished.